Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD34+/CD33+ blast cells: correlation with FAB subtypes

G M Rigolin1, F Lanza, L Ferrari

  • 1Institute of Haematology, University of Ferrara, Italy.

Leukemia & Lymphoma
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Description of 18 PNH patients with prevalent GPI-deficient monocytes. An Italian survey.

British journal of haematology·2025
Same author

Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2023
Same author

[Cultured platelets].

Bulletin de l'Academie nationale de medecine·2020
Same author

Head down tilt 15° in experimental intracerebral hemorrhage: a randomized noninferiority safety trial.

European journal of neurology·2020
Same author

Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2020
Same author

WITHDRAWN: Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2020
Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
See all related articles

This study combined morphology and flow cytometry to classify acute myeloid leukemia (AML) blasts, identifying subgroups with prognostic value. Morpho-immunological analysis improves AML classification and aids in defining precise prognostic subgroups.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • The FAB classification for acute myeloid leukemia (AML) has limited reproducibility (78.1%).
  • The prognostic impact of immunophenotyping in AML is debated due to inconsistent diagnostic criteria and methodologies.
  • Previous research suggests defining cell clusters based on morphology and marker expression for better AML characterization.

Purpose of the Study:

  • To investigate the morpho-immunological characteristics of AML blasts using flow cytometry.
  • To assess the concordance between a combined morpho-immunological approach and the FAB classification.
  • To explore the prognostic relevance of CD34 and CD33 expression intensity in AML.

Main Methods:

  • Analysis of blast CD34 and CD33 expression intensity in 65 AML patients classified by FAB criteria.

Related Experiment Videos

  • Grouping patients based on morphological features (side scatter and forward scatter) and immunophenotypic patterns.
  • Comparing the novel morpho-immunological classification with the established FAB criteria.

    • Main Results:

    • Four distinct morphological groups and five immunophenotypic patterns were identified.
    • The morpho-immunological analysis subdivided AML patients into 5 homogeneous subgroups with 73.9% concordance to FAB classification.
    • Correlation between CD34/CD33 expression intensity and prognosis was observed in M1-M2, M2, and M4 subgroups.

    Conclusions:

    • Flow cytometry-based morpho-immunological analysis can enhance understanding and agreement in AML classification across institutions.
    • This approach can assist in defining more precise prognostic subgroups for acute myeloid leukemia.
    • While not replacing the FAB classification, morpho-immunological analysis offers valuable complementary insights into AML.